BioCryst Pharmaceuticals【BCRX】株式ニュース

名称	銘柄コード	市場	種別
BioCryst Pharmaceuticals Inc	BCRX	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.05	-0.76%	6.52	07:36:17

始値	安値	高値	終値	前日終値
6.63	6.43	6.815	6.46	6.57

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/01	05:25	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/30	05:16	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/22	20:24	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/22	20:21	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/15	20:17	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/15	20:14	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/15	20:11	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/15	20:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/15	20:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/14	20:00	GLOBE	BioCryst to Present New Data at 2024 Meeting of the European..
2024/5/13	20:00	GLOBE	ORLADEYO® (berotralstat) Approved in Mexico
2024/5/09	20:00	GLOBE	BioCryst Presents New Real-world Evidence Showing..
2024/5/08	05:02	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/07	20:00	GLOBE	BioCryst to Present at Upcoming Investor Conferences
2024/5/06	20:03	EDGAR2	Form 8-K - Current report
2024/5/06	20:00	GLOBE	BioCryst Reports First Quarter 2024 Financial Results and..
2024/5/03	20:00	GLOBE	BioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
2024/4/22	20:00	GLOBE	BioCryst to Report First Quarter 2024 Financial Results on..
2024/4/17	17:30	GLOBE	BioCryst Announces Approval of ORLADEYO® (berotralstat) by..
2024/4/03	20:00	GLOBE	BioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
2024/3/26	05:01	GLOBE	BioCryst to Present at Upcoming Investor Conferences
2024/3/05	21:01	GLOBE	BioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
2024/3/05	07:25	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/05	06:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/28	07:05	EDGAR2	Form S-3ASR - Automatic shelf registration statement of..
2024/2/26	21:05	EDGAR2	Form 8-K - Current report
2024/2/26	21:00	GLOBE	BioCryst Reports Fourth Quarter and Full Year 2023 Financial..
2024/2/26	19:57	IHMARKETNEWS	U.S. Index Futures Dip Amid Inflation Data Anticipation, Oil..
2024/2/23	21:00	GLOBE	BioCryst Presents New Real-world Data Showing Rapid,..
2024/2/22	06:01	GLOBE	BioCryst to Present at Upcoming Investor Conferences
2024/2/19	21:54	GLOBE	BioCryst Launches ORLADEYO® (berotralstat) in Italy
2024/2/15	06:21	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/14	23:02	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2024/2/12	21:00	GLOBE	BioCryst to Report Fourth Quarter 2023 Financial Results on..
2024/2/05	21:00	GLOBE	BioCryst to Present New ORLADEYO® (berotralstat) Real-world..
2024/2/02	21:00	GLOBE	BioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
2024/1/25	07:23	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/19	07:21	EDGAR2	Form 8-K - Current report
2024/1/08	21:02	EDGAR2	Form 8-K - Current report
2024/1/06	06:01	GLOBE	BioCryst Announces Preliminary Full Year 2023 ORLADEYO®..
2024/1/05	06:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/04	06:01	GLOBE	BioCryst Reports Inducement Grants Under Nasdaq Listing Rule..
2024/1/03	21:00	GLOBE	BioCryst to Present at 42nd Annual J.P. Morgan Healthcare..
2023/12/21	06:42	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/21	06:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/21	06:38	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/21	06:35	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/21	06:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/19	21:00	GLOBE	BioCryst Announces Publication of Data from Open-label..
2023/12/19	06:47	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..